Mednet Logo
HomeQuestion

How would you approach therapy for BR-refractory Waldenstrom Macroglobulinemia when there is a mixed response to zanabrutinib?

2
1 Answers
Mednet Member
Mednet Member
Hematology · University of California Irvine

It goes without saying this is a “data-free zone.” I would consider extrapolating from CLL and adding venetoclax.

Register or Sign In to see full answer

How would you approach therapy for BR-refractory Waldenstrom Macroglobulinemia when there is a mixed response to zanabrutinib? | Mednet